Understanding the Unfolded Protein Response (UPR) Pathway: Insights into Neuropsychiatric Disorders and Therapeutic Potentials

Overview

Journal Biomol Ther (Seoul)

Specialty Pharmacology

Date 2024 Feb 27

PMID 38410073

Authors

Pitna Kim

Affiliations

Soon will be listed here.

Abstract

The Unfolded Protein Response (UPR) serves as a critical cellular mechanism dedicated to maintaining protein homeostasis, primarily within the endoplasmic reticulum (ER). This pathway diligently responds to a variety of intracellular indicators of ER stress with the objective of reinstating balance by diminishing the accumulation of unfolded proteins, amplifying the ER's folding capacity, and eliminating slow-folding proteins. Prolonged ER stress and UPR irregularities have been linked to a range of neuropsychiatric disorders, including major depressive disorder, bipolar disorder, and schizophrenia. This review offers a comprehensive overview of the UPR pathway, delineating its activation mechanisms and its role in the pathophysiology of neuropsychiatric disorders. It highlights the intricate interplay within the UPR and its profound influence on brain function, synaptic perturbations, and neural developmental processes. Additionally, it explores evolving therapeutic strategies targeting the UPR within the context of these disorders, underscoring the necessity for precision and further research to effective treatments. The research findings presented in this work underscore the promising potential of UPR-focused therapeutic approaches to address the complex landscape of neuropsychiatric disorders, giving rise to optimism for improving outcomes for individuals facing these complex conditions.

Citing Articles

The Interplay Between Endoplasmic Reticulum Stress and Ferroptosis in Neurological Diseases.

Zhai T, Wang B, Shi C, Zhang C, Shen J, Feng X Neurochem Res. 2025; 50(2):99.

PMID: 39928173 DOI: 10.1007/s11064-025-04348-4.

Emerging and Promising Keywords in Biomolecules and Therapeutics for 21st Century Diseases.

Ko H, Lee C Biomol Ther (Seoul). 2024; 33(1):1-4.

PMID: 39725476 PMC: 11704395. DOI: 10.4062/biomolther.2024.007.

Dissecting Schizophrenia Biology Using Pleiotropy with Cognitive Genomics.

Bhattacharyya U, John J, Lencz T, Lam M medRxiv. 2024; .

PMID: 38699340 PMC: 11065000. DOI: 10.1101/2024.04.16.24305885.

References

Nadarajah B, Parnavelas J . Modes of neuronal migration in the developing cerebral cortex. Nat Rev Neurosci. 2002; 3(6):423-32. DOI: 10.1038/nrn845. View

Kawada K, Iekumo T, Saito R, Kaneko M, Mimori S, Nomura Y . Aberrant neuronal differentiation and inhibition of dendrite outgrowth resulting from endoplasmic reticulum stress. J Neurosci Res. 2014; 92(9):1122-33. PMC: 4320781. DOI: 10.1002/jnr.23389. View

Reinhardt S, Schuck F, Grosgen S, Riemenschneider M, Hartmann T, Postina R . Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease. FASEB J. 2013; 28(2):978-97. DOI: 10.1096/fj.13-234864. View

Lee A . The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem Sci. 2001; 26(8):504-10. DOI: 10.1016/s0968-0004(01)01908-9. View

Wang M, Kaufman R . The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat Rev Cancer. 2014; 14(9):581-97. DOI: 10.1038/nrc3800. View

Hetz C, Zhang K, Kaufman R . Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020; 21(8):421-438. PMC: 8867924. DOI: 10.1038/s41580-020-0250-z. View

Lee A, Delegeane A, Scharff D . Highly conserved glucose-regulated protein in hamster and chicken cells: preliminary characterization of its cDNA clone. Proc Natl Acad Sci U S A. 1981; 78(8):4922-5. PMC: 320295. DOI: 10.1073/pnas.78.8.4922. View

Grandjean J, Wiseman R . Small molecule strategies to harness the unfolded protein response: where do we go from here?. J Biol Chem. 2020; 295(46):15692-15711. PMC: 7667976. DOI: 10.1074/jbc.REV120.010218. View

Hollien J, Lin J, Li H, Stevens N, Walter P, Weissman J . Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J Cell Biol. 2009; 186(3):323-31. PMC: 2728407. DOI: 10.1083/jcb.200903014. View

10.

Zhang L, Zhang X . Roles of GRP78 in physiology and cancer. J Cell Biochem. 2010; 110(6):1299-305. DOI: 10.1002/jcb.22679. View

11.

Zhao F, Li B, Yang W, Ge T, Cui R . Brain-immune interaction mechanisms: Implications for cognitive dysfunction in psychiatric disorders. Cell Prolif. 2022; 55(10):e13295. PMC: 9528770. DOI: 10.1111/cpr.13295. View

12.

Edvardson S, Nicolae C, Noh G, Burton J, Punzi G, Shaag A . Heterozygous RNF13 Gain-of-Function Variants Are Associated with Congenital Microcephaly, Epileptic Encephalopathy, Blindness, and Failure to Thrive. Am J Hum Genet. 2019; 104(1):179-185. PMC: 6323416. DOI: 10.1016/j.ajhg.2018.11.018. View

13.

Hetz C, Saxena S . ER stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol. 2017; 13(8):477-491. DOI: 10.1038/nrneurol.2017.99. View

14.

Xue X, Wu X, Liu L, Liu L, Zhu F . ERVW-1 Activates ATF6-Mediated Unfolded Protein Response by Decreasing GANAB in Recent-Onset Schizophrenia. Viruses. 2023; 15(6). PMC: 10304270. DOI: 10.3390/v15061298. View

15.

Vasquez G, Medinas D, Urra H, Hetz C . Emerging roles of endoplasmic reticulum proteostasis in brain development. Cells Dev. 2022; 170:203781. DOI: 10.1016/j.cdev.2022.203781. View

16.

Freeman O, Mallucci G . The UPR and synaptic dysfunction in neurodegeneration. Brain Res. 2016; 1648(Pt B):530-537. DOI: 10.1016/j.brainres.2016.03.029. View

17.

Hollien J, Weissman J . Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science. 2006; 313(5783):104-7. DOI: 10.1126/science.1129631. View

18.

Han J, Murthy R, Wood B, Song B, Wang S, Sun B . ER stress signalling through eIF2α and CHOP, but not IRE1α, attenuates adipogenesis in mice. Diabetologia. 2013; 56(4):911-24. PMC: 3606029. DOI: 10.1007/s00125-012-2809-5. View

19.

Halliday M, Mallucci G . Targeting the unfolded protein response in neurodegeneration: A new approach to therapy. Neuropharmacology. 2013; 76 Pt A:169-74. DOI: 10.1016/j.neuropharm.2013.08.034. View

20.

Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents N, Arias C . XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol Cell. 2007; 27(1):53-66. DOI: 10.1016/j.molcel.2007.06.011. View